Compare BRNS & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRNS | CMBM |
|---|---|---|
| Founded | 2016 | 2011 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 55.9M | 65.5M |
| IPO Year | 2021 | 2019 |
| Metric | BRNS | CMBM |
|---|---|---|
| Price | $0.73 | $1.64 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | 103.6K | ★ 2.4M |
| Earning Date | 11-07-2025 | 02-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $172,215,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $18.01 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1766.46 | N/A |
| 52 Week Low | $0.64 | $0.23 |
| 52 Week High | $2.92 | $6.80 |
| Indicator | BRNS | CMBM |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 43.85 |
| Support Level | $0.68 | $1.74 |
| Resistance Level | $0.78 | $2.18 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | 0.02 | -0.06 |
| Stochastic Oscillator | 39.85 | 20.29 |
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.